Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.

Doss M, Zhang JJ, Bélanger MJ, Stubbs JB, Hostetler ED, Alpaugh K, Kolb HC, Yu JQ.

Nucl Med Commun. 2010 Dec;31(12):1016-24. doi: 10.1097/MNM.0b013e3283407950.

2.

Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.

Doss M, Kolb HC, Zhang JJ, Bélanger MJ, Stubbs JB, Stabin MG, Hostetler ED, Alpaugh RK, von Mehren M, Walsh JC, Haka M, Mocharla VP, Yu JQ.

J Nucl Med. 2012 May;53(5):787-95. doi: 10.2967/jnumed.111.088955. Epub 2012 Apr 12.

3.

Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.

Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu Z, Alpaugh RK, Lango MN, Yu JQ.

J Nucl Med. 2013 Dec;54(12):2087-92. doi: 10.2967/jnumed.113.119800. Epub 2013 Oct 17.

4.

Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.

Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F, Giacomelli F, Degueldre C, Hustinx R, Luxen A, Seret A, Plenevaux A, Salmon E.

Mol Imaging Biol. 2015 Aug;17(4):557-64. doi: 10.1007/s11307-014-0820-6.

PMID:
25595813
5.

Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers.

Doss M, Kolb HC, Walsh JC, Mocharla VP, Zhu Z, Haka M, Alpaugh RK, Chen DY, Yu JQ.

Mol Imaging Biol. 2014 Oct;16(5):739-46. doi: 10.1007/s11307-014-0730-7.

PMID:
24696183
6.

Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.

Challapalli A, Sharma R, Hallett WA, Kozlowski K, Carroll L, Brickute D, Twyman F, Al-Nahhas A, Aboagye EO.

J Nucl Med. 2014 Feb;55(2):256-63. doi: 10.2967/jnumed.113.129577.

7.

Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.

Herzog H, Elmenhorst D, Winz O, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x. Epub 2008 Mar 29.

PMID:
18373090
8.

The clinical safety, biodistribution and internal radiation dosimetry of [¹⁸F]fluciclovine in healthy adult volunteers.

McParland BJ, Wall A, Johansson S, Sørensen J.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1256-64. doi: 10.1007/s00259-013-2403-1. Epub 2013 Apr 24.

PMID:
23613104
9.

Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.

Sprague DR, Chin FT, Liow JS, Fujita M, Burns HD, Hargreaves R, Stubbs JB, Pike VW, Innis RB, Mozley PD.

J Nucl Med. 2007 Jan;48(1):100-7.

10.

Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.

Smolarz K, Krause BJ, Graner FP, Wagner FM, Wester HJ, Sell T, Bacher-Stier C, Fels L, Dinkelborg L, Schwaiger M.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1861-8. doi: 10.1007/s00259-013-2502-z. Epub 2013 Jul 23.

PMID:
23877631
11.

Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans.

Garg PK, Lokitz SJ, Nazih R, Garg S.

J Nucl Med. 2017 Mar;58(3):473-478. doi: 10.2967/jnumed.116.180059. Epub 2016 Sep 22.

PMID:
27660145
12.

Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.

Constantinescu CC, Sevrioukov E, Garcia A, Pan ML, Mukherjee J.

Mol Imaging Biol. 2013 Apr;15(2):222-9. doi: 10.1007/s11307-012-0582-y.

13.

(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.

Smolarz K, Krause BJ, Graner FP, Wagner FM, Hultsch C, Bacher-Stier C, Sparks RB, Ramsay S, Fels LM, Dinkelborg LM, Schwaiger M.

J Nucl Med. 2013 Jun;54(6):861-6. doi: 10.2967/jnumed.112.112581. Epub 2013 Apr 8.

14.

PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.

López-Rodríguez V, Galindo-Sarco C, García-Pérez FO, Ferro-Flores G, Arrieta O, Ávila-Rodríguez MA.

J Nucl Med. 2016 Mar;57(3):404-9. doi: 10.2967/jnumed.115.161653. Epub 2015 Nov 19.

15.

18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.

Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.

J Nucl Med. 2013 Sep;54(9):1551-6. doi: 10.2967/jnumed.112.118760. Epub 2013 Aug 15.

16.

First evaluation of PET based human biodistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia.

Savi A, Incerti E, Fallanca F, Bettinardi V, Rossetti F, Monterisi C, Compierchio A, Negri G, Zannini P, Gianolli L, Picchio M.

J Nucl Med. 2017 Feb 16. pii: jnumed.113.122671. doi: 10.2967/jnumed.113.122671. [Epub ahead of print]

PMID:
28209906
17.

Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice.

Constantinescu CC, Garcia A, Mirbolooki MR, Pan ML, Mukherjee J.

Nucl Med Biol. 2013 Feb;40(2):289-94. doi: 10.1016/j.nucmedbio.2012.11.004. Epub 2012 Dec 21.

18.

Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.

Sattler B, Kranz M, Starke A, Wilke S, Donat CK, Deuther-Conrad W, Patt M, Schildan A, Patt J, Smits R, Hoepping A, Schoenknecht P, Steinbach J, Brust P, Sabri O.

J Nucl Med. 2014 Nov;55(11):1885-92. doi: 10.2967/jnumed.114.137059. Epub 2014 Oct 6.

19.

Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.

Tavares AA, Caillé F, Barret O, Papin C, Lee H, Morley TJ, Fowles K, Holden D, Seibyl JP, Alagille D, Tamagnan GD.

Nucl Med Biol. 2014 May-Jun;41(5):432-9. doi: 10.1016/j.nucmedbio.2014.02.005. Epub 2014 Feb 28.

PMID:
24674817
20.

Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Laymon CM, Narendran R, Mason NS, Carney JP, Lopresti BJ, Mathis CA, Mountz JM, Sashin D, Frankle WG.

Mol Imaging Biol. 2012 Feb;14(1):115-22. doi: 10.1007/s11307-011-0478-2.

PMID:
21365327

Supplemental Content

Support Center